公開日期 | 標題 | 作者 | 來源出版物 | scopus | WOS | 全文 |
2018 | Acylguanidine derivatives of zanamivir and oseltamivir: Potential orally available prodrugs against influenza viruses | Hsu, P.-H.; Chiu, D.-C.; Wu, K.-L.; Lee, P.-S.; Jan, J.-T.; Cheng, Y.-S.E.; Tsai, K.-C.; Cheng, T.-J.; Fang, J.-M. | European Journal of Medicinal Chemistry | 23 | 23 | |
2019 | Boronate, trifluoroborate, sulfone, sulfinate and sulfonate congeners of oseltamivir carboxylic acid: Synthesis and anti-influenza activity | Hong, B.-T.; Cheng, Y.-S.E.; Cheng, T.-J.; Fang, J.-M. | European Journal of Medicinal Chemistry | 7 | 7 | |
2009 | Determination of tannic acid precipitated with bovine serum albumin by visible light scattering by a flow-injection system | Cheng, T.-J.; Chung, C.-Y.; Chen, P.-C.; RICHIE CHEN | IFMBE Proceedings | | | |
2017 | Peramivir analogues bearing hydrophilic side chains exhibit higher activities against H275Y mutant than wild-type influenza virus | Chiu, D.-C.; Lin, T.-C.; Huang, W.-I.; Cheng, T.-J.; Tsai, K.-C.; Fang, J.-M. | Organic and Biomolecular Chemistry | 12 | 12 | |
2018 | Peramivir conjugates as orally available agents against influenza H275Y mutant | Wang, P.-C.; Chiu, D.-C.; Jan, J.-T.; Huang, W.-I.; Tseng, Y.-C.; Li, T.-T.; Cheng, T.-J.; Tsai, K.-C.; Fang, J.-M. | European Journal of Medicinal Chemistry | 16 | 15 | |
2018 | Structure-based design of bacterial transglycosylase inhibitors incorporating biphenyl, amine linker and 2-alkoxy-3-phosphorylpropanoate moieties | Yu, J.-Y.; Cheng, H.-J.; Wu, H.-R.; Wu, W.-S.; Lu, J.-W.; Cheng, T.-J.; Wu, Y.-T.; Fang, J.-M. | European Journal of Medicinal Chemistry | 5 | 4 | |
2019 | Structure-guided development of purine amide, hydroxamate, and amidoxime for the inhibition of non-small cell lung cancer | Huang, M.-R.; Hsu, Y.-L.; TAI-CHIA LIN; Cheng, T.-J.; Li, L.-W.; Tseng, Y.-W.; Chou, Y.-S.; Liu, J.-H.; SZU-HUA PAN ; Fang, J.-M. ; Wong, C.-H. | European Journal of Medicinal Chemistry | 13 | 12 | |